US 10501740
Compositions and methods for inhibiting expression of factor V
granted A61KA61K47/554A61K48/00
Quick answer
US patent 10501740 (Compositions and methods for inhibiting expression of factor V) held by Alnylam Pharmaceuticals, Inc. expires Mon Dec 05 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Alnylam Pharmaceuticals, Inc.
- Grant date
- Tue Dec 10 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 05 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61K, A61K47/554, A61K48/00, A61P, A61P7/02